Skip to main content

Subarachnoid meperidine (Pethidine) causes significant nausea and vomiting during labor. The Duke Women's Anesthesia Research Group.

Publication ,  Journal Article
Booth, JV; Lindsay, DR; Olufolabi, AJ; El-Moalem, HE; Penning, DH; Reynolds, JD
Published in: Anesthesiology
August 2000

BACKGROUND: The combined spinal-epidural (CSE) technique using bupivicaine-fentanyl has become an established method of pain control during parturition. One limitation is the relatively short duration of effective analgesia produced by bupivicaine-fentanyl. In contrast, subarachnoid meperidine has been shown to provide a long duration of anesthesia in nonobstetric patients. Therefore, the authors tested the hypothesis that subarachnoid meperidine produces a significant increase in the duration of analgesia compared with bupivicaine-fentanyl. METHODS: Based on a power analysis of preliminary data, the authors intended to recruit 90 patients for the study, randomized to three groups: 2.5 mg bupivicaine-25 microg fentanyl, 15 mg meperidine, or 25 mg meperidine. However, after enrolling 34 patients, the study was discontinued because of a significant increase in nausea or vomiting in the study patients. RESULTS: Nausea or vomiting was substantially increased in both meperidine groups compared with the bupivicaine-fentanyl group: 16 with nausea or vomiting in the meperidine groups (n = 21), compared with 1 in the bupivicaine-fentanyl group (n = 11), P = 0.0011. The mean duration of analgesia provided by 25 mg meperidine was 126 +/- 51 min, compared with 98 +/- 29 min for bupivicaine-fentanyl and 90 +/- 67 min for 15 mg meperidine. These data were not significant (P = 0.27). CONCLUSIONS: Although intrathecal meperidine could potentially prolong subarachnoid analgesia during labor, its use was associated with a significant incidence of nausea or vomiting. These data do not support the use of subarachnoid meperidine in doses of 15 or 25 mg for labor analgesia.

Duke Scholars

Published In

Anesthesiology

DOI

ISSN

0003-3022

Publication Date

August 2000

Volume

93

Issue

2

Start / End Page

418 / 421

Location

United States

Related Subject Headings

  • Subarachnoid Space
  • Pregnancy
  • Postoperative Nausea and Vomiting
  • Pain Measurement
  • Meperidine
  • Humans
  • Fentanyl
  • Female
  • Dose-Response Relationship, Drug
  • Bupivacaine
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Booth, J. V., Lindsay, D. R., Olufolabi, A. J., El-Moalem, H. E., Penning, D. H., & Reynolds, J. D. (2000). Subarachnoid meperidine (Pethidine) causes significant nausea and vomiting during labor. The Duke Women's Anesthesia Research Group. Anesthesiology, 93(2), 418–421. https://doi.org/10.1097/00000542-200008000-00020
Booth, J. V., D. R. Lindsay, A. J. Olufolabi, H. E. El-Moalem, D. H. Penning, and J. D. Reynolds. “Subarachnoid meperidine (Pethidine) causes significant nausea and vomiting during labor. The Duke Women's Anesthesia Research Group.Anesthesiology 93, no. 2 (August 2000): 418–21. https://doi.org/10.1097/00000542-200008000-00020.
Booth JV, Lindsay DR, Olufolabi AJ, El-Moalem HE, Penning DH, Reynolds JD. Subarachnoid meperidine (Pethidine) causes significant nausea and vomiting during labor. The Duke Women's Anesthesia Research Group. Anesthesiology. 2000 Aug;93(2):418–21.
Booth, J. V., et al. “Subarachnoid meperidine (Pethidine) causes significant nausea and vomiting during labor. The Duke Women's Anesthesia Research Group.Anesthesiology, vol. 93, no. 2, Aug. 2000, pp. 418–21. Pubmed, doi:10.1097/00000542-200008000-00020.
Booth JV, Lindsay DR, Olufolabi AJ, El-Moalem HE, Penning DH, Reynolds JD. Subarachnoid meperidine (Pethidine) causes significant nausea and vomiting during labor. The Duke Women's Anesthesia Research Group. Anesthesiology. 2000 Aug;93(2):418–421.

Published In

Anesthesiology

DOI

ISSN

0003-3022

Publication Date

August 2000

Volume

93

Issue

2

Start / End Page

418 / 421

Location

United States

Related Subject Headings

  • Subarachnoid Space
  • Pregnancy
  • Postoperative Nausea and Vomiting
  • Pain Measurement
  • Meperidine
  • Humans
  • Fentanyl
  • Female
  • Dose-Response Relationship, Drug
  • Bupivacaine